NCT00616317Recruiting

Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

University of California, Davis

Start Date

9/1/2006

Completion Date

1/1/2040

Summary

The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.

Eligibility Criteria

Age Range: No minimum to 18 years

Inclusion Criteria: * 18 years of age or younger at the onset of disease * Presence of Vascular Thrombosis * UC Davis patient * Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma Exclusion Criteria: * Infants born to mothers with APS * Infants with congenital thrombophilia

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Antiphospholipid Syndrome

Locations

UC Davis Medical Center

Sacramento, California 95817

United States

Run studies, or work at a research site?

Corterve helps sites and sponsors reach patients who are looking for trials. It does not determine eligibility and does not promise an enrolment outcome.

For sponsors, CROs and sites

What Corterve sells to organisations, and the anti-kickback constraints it works within.

Services and published prices

Lay summaries for EU CTR Annex V, pre-screen filtration, recruitment-creative regulatory operations, feasibility reporting.

For research sites

One published licence rate, the same for every site, and the fees a site is never charged.